news release
- company news
shenzhen, [september 29] c&o today announces the launch of its first next-generation proton pump inhibitor, rabeprazole sodium for injection (aobo ping®), in china. aubergine® is a self-developed product of c&o.
rabeprazole sodium for injection (aobo ping®) has been approved for drug registration and will be launched soon!
contact telephone numbers for rabeprazole sodium for injection (aobo ping) in provinces
rabeprazole sodium for injection (aobo ping®) agent registration form
address5/f, jihao building, 1086 shennan east road, luohu district, shenzhen
adverse drug reactions / event feedback hotline025-6816 1304
adverse drug reactions / event feedback mailgvp@changao.com
official wechat account mobile page